{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:31:50Z","timestamp":1779337910353,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clml.2024.09.003","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T10:47:11Z","timestamp":1726138031000},"page":"e90-e95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Influence of Obesity on the Efficacy and Toxicity of Patients Undergoing Autologous Hematopoietic Cell Transplantation for Lymphoma"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7446-142X","authenticated-orcid":false,"given":"Andrew","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parastoo","family":"Dahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel-Angel","family":"Perales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Scordo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunjan L.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2024.09.003_bib0001","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1634\/theoncologist.2011-0177","article-title":"Current status of autologous stem cell transplantation in relapsed and refractory Hodgkin's lymphoma","volume":"17","author":"Colpo","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.clml.2024.09.003_bib0002","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1634\/theoncologist.2009-0162","article-title":"Controversies in the treatment of lymphoma with autologous transplantation","volume":"14","author":"Moskowitz","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.clml.2024.09.003_bib0003","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1586\/ehm.09.24","article-title":"Transplantation for non-Hodgkin lymphoma","volume":"2","author":"Nademanee","year":"2009","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.clml.2024.09.003_bib0004","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-200039030-00004","article-title":"Effects of obesity on pharmacokinetics: implications for drug therapy","volume":"39","author":"Cheymol","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clml.2024.09.003_bib0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans","volume":"49","author":"Hanley","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clml.2024.09.003_bib0006","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbmt.2014.01.019","article-title":"Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee","volume":"20","author":"Bubalo","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2024.09.003_bib0007","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bmt.1704052","article-title":"Impact of obesity in the setting of high-dose chemotherapy","volume":"31","author":"Navarro","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2024.09.003_bib0008","series-title":"Obesity and overweight","year":"2021"},{"issue":"17","key":"10.1016\/j.clml.2024.09.003_bib0009","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.clml.2024.09.003_bib0010","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2011.06.029","article-title":"Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a metaanalysis of prospective studies","volume":"47","author":"Larsson","year":"2011","journal-title":"Eur J Cancer"},{"issue":"48","key":"10.1016\/j.clml.2024.09.003_bib0011","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jncimonographs\/lgu013","article-title":"Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Morton","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"5","key":"10.1016\/j.clml.2024.09.003_bib0012","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bbmt.2005.12.033","article-title":"Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation","volume":"12","author":"Navarro","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.clml.2024.09.003_bib0013","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.bmt.1702692","article-title":"Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft","volume":"26","author":"Tarella","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2024.09.003_bib0014","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbmt.2018.11.005","article-title":"Effect of conditioning regimen dose reduction in obese patients undergoing autologous hematopoietic cell transplantation","volume":"25","author":"Brunstein","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2024.09.003_bib0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/bmt.2016.316","article-title":"BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modifications","volume":"52","author":"Fair","year":"2017","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.clml.2024.09.003_bib0016","first-page":"650","article-title":"Clinical pharmacy case studies. Case number 25: gentamicin therapy","volume":"8","author":"Devine","year":"1974","journal-title":"Drug Intell Clin Pharm"},{"issue":"3","key":"10.1016\/j.clml.2024.09.003_bib0017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1200\/JOP.200016","article-title":"Description of current practices of empiric chemotherapy dose adjustment in obese adult patients","volume":"6","author":"Thompson","year":"2010","journal-title":"J Oncol Pract"},{"issue":"6","key":"10.1016\/j.clml.2024.09.003_bib0018","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbmt.2015.02.005","article-title":"Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation","volume":"21","author":"Chen","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2024.09.003_bib0019","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2024.09.003_bib0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1083-8791(99)70005-4","article-title":"Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation","volume":"5","author":"Dickson","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2024.09.003_bib0021","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40262-021-01093-z","article-title":"Population pharmacokinetics of melphalan in a large cohort of autologous and allogeneic hematopoietic cell transplantation recipients: towards individualized dosing regimens","volume":"61","author":"Shah","year":"2022","journal-title":"Clin Pharmacokinet"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024018172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024018172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T10:59:25Z","timestamp":1738061965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265024018172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2152265024018172"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2024.09.003","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of Obesity on the Efficacy and Toxicity of Patients Undergoing Autologous Hematopoietic Cell Transplantation for Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2024.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}